A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics and
pharmacodynamics (how the drug effects certain target sites of activity in the body) of
escalating doses of oral PF-04171327 in healthy volunteers for 14 days (Part 1). Part 2 will
evaluate the pharmacokinetics of a single 10 mg dose of the PF-04171327 tablet in healthy
volunteers.